Category Archives: drug response

New gene identified in multiple sclerosis disease activity.

A new study led by investigators at Brigham and Women’s Hospital (BWH) reports the discovery of a genetic variant that is associated with a patient’s likelihood of responding to interferon-beta, one of the medications used in treating multiple sclerosis (MS). Published in the Annals of Neurology, the new study also presents evidence that the affected gene, SLC9A9, may have a

Read more